| Authors: |
Lee MS; Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, USA., Bunin DI; Biosciences Division, SRI International, Menlo Park, CA, USA., Furimsky AM; Biosciences Division, SRI International, Menlo Park, CA, USA., Nguyen D; Biosciences Division, SRI International, Menlo Park, CA, USA., Parman T; Sangamo Therapeutics, Brisbane, CA, USA., Kim K; Jazz Pharmaceuticals, Palo Alto, CA, USA., Rausch L; Biosciences Division, SRI International, Menlo Park, CA, USA., Lin MT; Piramal Pharma Solutions, Riverview, MI, USA., Gupta P; Piramal Pharma Solutions, Riverview, MI, USA., Brown JE; Department of Gynecologic Surgery & Obstetrics, Uniformed Services University, Bethesda, MD, USA., Kroopnick JM; Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, USA., Blithe DL; Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, USA. |